Table 2 Correlation between miR-182-5p expression and clinicopathological characteristics of renal cell cancer patients [3, 48, 49] (Clear cell renal cell carcinoma)
Characteristics | Total | Expression of miR-182-5p | P value | |
|---|---|---|---|---|
High (n = 24) | Low (n = 64) | |||
Gender | ||||
 Male | 47 | 11 (23.4%) | 36 (76.6%) | 0.474 |
 Female | 41 | 13 (31.7) | 28 (68.3%) |  |
Tumor size (cm) | ||||
  ≤ 7 cm | 50 | 16 (32.0%) | 34 (68.0%) | 0.335 |
 >7 cm | 38 | 8 (21.1%) | 30 (78.9%) |  |
Age | ||||
 ≤ 55 | 43 | 15 (34.9%) | 28 (65.1%) | 0.152 |
  > 55 | 45 | 9 (20.0%) | 36 (80.0%) |  |
Differentiation | ||||
 Moderate/poor | 50 | 8 (16.0%) | 42 (84.0%) | 0.008** |
 Well | 38 | 16 (42.1%) | 22((57.9%) |  |
TNM stage | ||||
 T0–1 | 26 | 12 (11.5%) | 14 (88.5%) | 0.017* |
 T2–4 | 62 | 12 (38.7%) | 50 (61.3%) |  |
Lymph node metastasis(N) | ||||
 N0 | 79 | 21 (26.6%) | 58 (73.4%) | 0.700 |
 N1 or above | 9 | 3 (33.3%) | 6 (66.7%) |  |